These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 3010426)

  • 1. HLA-DR2 and Dw2 in narcolepsy and in other disorders of excessive somnolence without cataplexy.
    Honda Y; Juji T; Matsuki K; Naohara T; Satake M; Inoko H; Someya T; Harada S; Doi Y
    Sleep; 1986; 9(1 Pt 2):133-42. PubMed ID: 3010426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA antigens in narcolepsy and idiopathic central nervous system hypersomnolence.
    Poirier G; Montplaisir J; Décary F; Momège D; Lebrun A
    Sleep; 1986; 9(1 Pt 2):153-8. PubMed ID: 3486443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Narcolepsy-cataplexy in Israeli Jews is associated exclusively with the HLA DR2 haplotype. A study at the serological and genomic level.
    Wilner A; Steinman L; Lavie P; Peled R; Friedmann A; Brautbar C
    Hum Immunol; 1988 Jan; 21(1):15-22. PubMed ID: 2896649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Narcolepsy and HLA in the Japanese.
    Juji T; Matsuki K; Tokunaga K; Naohara T; Honda Y
    Ann N Y Acad Sci; 1988; 540():106-14. PubMed ID: 2905117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of HLA-DR2, DQw1 negative post-traumatic narcolepsy].
    Maeda M; Tamaoka A; Hayashi A; Mizusawa H; Shoji S
    Rinsho Shinkeigaku; 1995 Jul; 35(7):811-3. PubMed ID: 8777810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The narcolepsy-associated DRw15,DQw6,Dw2 haplotype has no unique HLA-DQA or -DQB restriction fragments and does not extend to the HLA-DP subregion.
    Olerup O; Schaffer M; Hillert J; Sachs C
    Immunogenetics; 1990; 32(1):41-4. PubMed ID: 1973684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the occurrence of HLA DR2 in 124 narcoleptics: clinical aspects.
    Roth B; Nevsímalová S; Sonka K; Docekal P; Schulz H; Geisler P; Pollmächer T; Andreas-Zietz A; Keller E; Scholz S
    Schweiz Arch Neurol Psychiatr (1985); 1988; 139(4):41-51. PubMed ID: 2459761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DR restriction-fragment-length polymorphisms in narcolepsy.
    Holloman JD; Bell JI; Kilduff TS; Dement WC; Guilleminault C; McDevitt HO
    J Neurosci Res; 1987; 18(1):239-44. PubMed ID: 2890770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between HLA antigens and different types of hypersomnia.
    Montplaisir J; Poirier G; Décary F; Lebrun A
    JAMA; 1986 May; 255(17):2295-6. PubMed ID: 3485730
    [No Abstract]   [Full Text] [Related]  

  • 10. MHC class II sequences of an HLA-DR2 narcoleptic.
    Lock CB; So AK; Welsh KI; Parkes JD; Trowsdale J
    Immunogenetics; 1988; 27(6):449-55. PubMed ID: 3259543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human histocompatibility leukocyte antigen (HLA) haplotype frequencies estimated from the data on HLA class I, II, and III antigens in 111 Japanese narcoleptics.
    Matsuki K; Juji T; Tokunaga K; Naohara T; Satake M; Honda Y
    J Clin Invest; 1985 Dec; 76(6):2078-83. PubMed ID: 3865934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy.
    Mignot E; Kimura A; Lattermann A; Lin X; Yasunaga S; Mueller-Eckhardt G; Rattazzi C; Lin L; Guilleminault C; Grumet FC; Mayer G; Dement WC; Underhill P
    Tissue Antigens; 1997 Apr; 49(4):329-41. PubMed ID: 9151385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DR2 and narcolepsy.
    Billiard M; Seignalet J; Besset A; Cadilhac J
    Sleep; 1986; 9(1 Pt 2):149-52. PubMed ID: 3486442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA polymorphism related to HLA-DR2 Dw2 in patients with narcolepsy.
    Marcadet A; Gebuhrer L; Betuel H; Seignalet J; Freidel AC; Confavreux C; Billiard M; Dausset J; Cohen D
    Immunogenetics; 1985; 22(6):679-83. PubMed ID: 3000935
    [No Abstract]   [Full Text] [Related]  

  • 15. [HLA and narcolepsy. Apropos of 28 cases including 2 negative HLA-DR2].
    Confavreux C; Gebuhrer L; Betuel H; Freidel C; Bastuji H; Jouvet M; Aimard G; Devic M
    Rev Neurol (Paris); 1988; 144(5):327-31. PubMed ID: 3262232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA class II analysis in Jewish Israeli narcoleptic patients.
    Kwon OJ; Peled N; Miller K; Pillar G; Peled R; Lavie P; Brautbar C; Amar A
    Hum Immunol; 1995 Dec; 44(4):199-202. PubMed ID: 8770632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of polygenic risks for narcolepsy and essential hypersomnia.
    Yamasaki M; Miyagawa T; Toyoda H; Khor SS; Liu X; Kuwabara H; Kano Y; Shimada T; Sugiyama T; Nishida H; Sugaya N; Tochigi M; Otowa T; Okazaki Y; Kaiya H; Kawamura Y; Miyashita A; Kuwano R; Kasai K; Tanii H; Sasaki T; Honda Y; Honda M; Tokunaga K
    J Hum Genet; 2016 Oct; 61(10):873-878. PubMed ID: 27305985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DQ beta chain DNA restriction fragments can differentiate between healthy and narcoleptic individuals with HLA-DR2.
    Inoko H; Ando A; Tsuji K; Matsuki K; Juji T; Honda Y
    Immunogenetics; 1986; 23(2):126-8. PubMed ID: 3007343
    [No Abstract]   [Full Text] [Related]  

  • 20. No difference in the nucleotide sequence of the DQ beta beta 1 domain between narcoleptic and healthy individuals with DR2,Dw2.
    Uryu N; Maeda M; Nagata Y; Matsuki K; Juji T; Honda Y; Kawai J; Ando A; Tsuji K; Inoko H
    Hum Immunol; 1989 Mar; 24(3):175-81. PubMed ID: 2494138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.